The largest database of trusted experimental protocols

Mimic nc and inhibitor nc

Manufactured by GenePharma
Sourced in China

Mimic NC and inhibitor NC are cell transfection reagents designed for the effective delivery of small interfering RNA (siRNA) or microRNA (miRNA) molecules into mammalian cells. These products facilitate the study of gene function and regulation by enabling the modulation of target gene expression. The core function of these reagents is to efficiently transport the desired RNA molecules into cells, allowing for the investigation of their biological effects.

Automatically generated - may contain errors

5 protocols using mimic nc and inhibitor nc

1

In Vitro Manipulation of miR-136 in Trophoblast Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To achieve the in vitro manipulation of miR-136, human trophoblast cell lines HRT-8/SVneo and BeWo were transfected with miR-136 mimics, miR-136 inhibitors, or negative controls (mimic NC and inhibitor NC) (GenePharma, Shanghai, China) by Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). In addition, an overexpression vector of E2F1 pcDNA3.1-E2F1 was synthesized by GenePharma (Shanghai, China) and was transfected into trophoblast cells using Lipofectamine 2000 (Invitrogen). The cell transfection experiment was performed according to the manufacturer's instruction. The subsequent cell analyses were carried out at 48 h posttransfection.
+ Open protocol
+ Expand
2

Transfection Efficiency Optimization

Check if the same lab product or an alternative is used in the 5 most similar protocols
The transfection reagents IFNG-AS1 siRNA (si-IFNG-AS1) and siRNA negative control (siRNA-NC), miR-627-3p mimic, miR-627-3p inhibitor, and corresponding NCs (mimic NC and inhibitor NC) were all obtained from GenePharma (Shanghai, China). After being incubated in 6-well plates and grown to a cell density of 50%, the cells were transfected with the transfection reagents for 24 h with the help of Lipofectamine 2000 reagent [18 (link)]. Transfection efficiency was measured using reverse transcription-quantitative PCR (RT-qPCR) 48 h post-transfection. The control group was the untreated cells.
+ Open protocol
+ Expand
3

DANCR Silencing via siRNA Transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transfection was initiated upon achieving a cell fusion rate reached of 70%. Small interfering (si) RNA targeting DANCR (si-DANCR) and its negative control (si-NC) or, as well as the miR-214-5p mimic, miR-214-5p inhibitor, and their negative control (mimic NC and inhibitor NC, obtained from GenePharma, China), were combined with the transfection reagent Lipofectamine 3000 (cat: 1,662,152, Invitrogen, USA) in DMEM. The mixture was then allowed to incubate for 20 min at room temperature. Subsequently, the prepared mixture was introduced into the cells, and the incubation continued for 6 h before replacing the DMEM.
+ Open protocol
+ Expand
4

Regulation of NEAT1 and NR4A2 by miR-511 in HNECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Small interfering RNAs (siRNAs) targeting NEAT1 (si-NEAT1) and NR4A2 (si-NR4A2) with their negative control (si-NC), and miR-511 mimics and miR-511 inhibitor with their negative control (NC mimic and NC inhibitor) were obtained from GenePharma (Shanghai, China). HNECs (1 x 105) were transfected with si-NEAT1, si-NR4A2, si-NC, miR-511, NC mimics, miR-511 inhibitor or NC inhibitor using Lipofectamine 2000 (Invitrogen, USA). HNECs were collected 48 h after transfection according to previous study [18 ].
+ Open protocol
+ Expand
5

Overexpression of KCNQ1OT1 in chondrocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The gene-overexpression vector (Ad-KCNQ1OT1) and the control vector (Vector) were purchased from GenScript Biotech Corp. (Nanjing, China). The small interfering RNAs against SIRT1 (SIRT1 siRNA) and negative control siRNAs (NC siRNA) were designed, synthesized and validated by Thermo Fisher Scientific (Waltham, MA, USA). MiR-128a-3p mimic, miR-128-3p inhibitor and the corresponding negative control (NC mimic and NC inhibitor) were designed and synthesized by GenePharma Corporation (Shanghai, China). All these plasmids and oligonucleotides were transfected into ATDC5 chondrocyte cells by using lipofectamine 2000 transfection reagent (Invitrogen, Carlsbad, USA) following the guidelines of the manufacturer. At 48 h after transfection, cells were harvested for further study.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!